The price of a popular diabetes drug is forcing an Omaha woman to rely on her daughter. They worry that Mounjaro’s weight-loss benefit is spurring demand and driving up the price they have to pay. Dorothy Anderson received a prescription from her doctor for Mounjaro earlier this year. “I had ended up in the hospital with a brain hemorrhage and my blood sugar levels were between 300 and 400,” Dorothy said. So she paid $47 for a new drug in March. But the price for another four-pack of pens in June could break the senior’s tight budget, because the cost she paid for Mounjaro has risen sharply in the past three months, and she proved it to us by calling her pharmacy. . Sure enough, she paid $47 in March, $158.16 in April and $273.34 in May. She worries that she can’t get an answer about how much she will pay her next and whether the price will go further in the wrong direction for June. If so, she says she will be forced to rely on her daughter to cover the costs. “Prescription, food and water, no one should have to choose between one of the three,” said Natalia Anderson, her daughter. Natalia helps others as a home care professional. She’s already paying for her mother’s prescription and now talking budget by doing the spending in community pantries and calculating other trips around the house. A Creighton University economist said a handful of factors pushed the drug into the stratosphere. US inflation Increasing demand Alternative uses, such as weight loss have to pay for the medicines I need. You know, I’ve been able to do that and keep and everything until it comes to this Mounjaro. And this Mounjaro is taking us out of business,” Dorothy said. According to ABC News, drugmaker Eli Lilly said Mounjaro could be approved by the Food and Drug Administration for weight loss as early as later this year. Dorothy says it’s the perfect drug to treat her diabetes and hopes officials respond. The company said: ‘Lilly is committed to helping people access the medicines they need and will continue to work with insurers, health systems and providers to help people with type 2 diabetes access Mounjaro”. Get the latest headlines from KETV NewsWatch 7
The price of a popular diabetes drug is forcing an Omaha woman to rely on her daughter.
They worry that Mounjaro’s weight-loss benefit is driving demand and driving up the price they have to pay.
Dorothy Anderson received a prescription from her doctor for Mounjaro earlier this year.
“I had ended up in the hospital with a brain hemorrhage and my blood sugar was between 300 and 400,” Dorothy said.
Then he paid $47 for a new drug in March.
But the price for another four-pack of pens in June could break the senior’s fixed-income budget, because the cost he’s paid for Mounjaro has risen sharply in the past three months, and he showed us that by calling his pharmacy.
Sure enough, it paid $47 in March, $158.16 in April, and $273.34 in May.
She is concerned that she may not get an answer on how much she will pay next and whether the price will go further in the wrong direction for June.
If so, she says she’ll be forced to rely on her daughter to cover the costs.
“Prescription, food and water, no one should have to make a choice between one of the three,” said Natalia Anderson, his daughter.
Natalia helps others as a home care professional.
She’s already paying for her mom’s prescription and is now talking budgeting by grocery shopping at community pantries and calculating other moves around the house.
A Creighton University economist said a handful of factors pushed the drug into the stratosphere.
- US inflation
- More demand
- Alternative uses, such as weight loss
“I don’t look for my kids to have to pay for the medications I need. You know, I’ve been able to do that and maintain and everything until it comes to this Mounjaro. And this Mounjaro is pricing us out of business,” Dorothy said.
According to ABC News, drugmaker Eli Lilly said Mounjaro could be approved by the Food and Drug Administration for weight loss as early as later this year.
But Dorothy says it’s the perfect drug to treat her diabetes and hopes officials will respond.
The company said: “Lilly is committed to helping people access the medicines they need and will continue to work with insurers, healthcare systems and providers to help people with type 2 diabetes access Mounjaro.”
Get the latest headlines from KETV NewsWatch 7
#Mounjaro #Skyrocketing #price #popular #diabetes #drug #forces #Omaha #mom #rely #daughter
